Q32 Bio Inc. (QTTB)

NASDAQ: QTTB · Real-Time Price · USD

9.25

+0.40 (4.52%)

Nov 6, 2026, 4:00 PM EST - Market closed

Q32 Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	289.59	48.3	77.97	25.62	43.89	32.25
Cash & Short-Term Investments	289.59	48.3	77.97	25.62	43.89	32.25
Cash Growth	490.52%	-38.05%	204.35%	-41.64%	36.12%	-
Other Receivables	0.56	0.56	0.56	0.76	1.06	0.91
Receivables	0.56	0.56	0.56	0.76	1.06	0.91
Prepaid Expenses	0.9	1.34	2.96	2.26	1.75	0.77
Other Current Assets	0.08	4.86	0.4	0.08	0.15	0.07
Total Current Assets	291.13	55.05	81.88	28.72	46.85	34
Property, Plant & Equipment	5.43	6.08	7.09	8.08	9.17	0.2
Long-Term Investments	-	-	2.6	-	-	-
Other Long-Term Assets	0.65	0.65	0.76	10.26	5.76	0.95
Total Assets	297.2	61.78	92.33	47.06	61.77	35.15

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.11	0.88	2.99	3.47	1.44	2.68
Accrued Expenses	3.3	3.54	6.87	8.91	8.46	4.54
Current Portion of Long-Term Debt	-	6.24	3.1	0.88	32.4	-
Current Portion of Leases	0.76	0.69	0.61	0.54	0.47	-
Current Income Taxes Payable	-	-	-	0.32	0.57	-
Current Unearned Revenue	-	-	-	-	14.53	-
Other Current Liabilities	-	-	2.9	-	-	-
Total Current Liabilities	5.17	11.35	16.47	14.11	57.87	7.22
Long-Term Debt	-	3.47	9.56	43.18	5.07	4.97
Long-Term Leases	4.36	4.94	5.64	6.25	6.79	-
Long-Term Unearned Revenue	-	-	-	-	11.32	-
Other Long-Term Liabilities	-	-	55	55	-	0.73
Total Liabilities	9.53	19.76	86.66	118.53	81.04	12.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	518.14	247.01	240.49	4.16	2.63	1.32
Retained Earnings	-230.47	-204.99	-234.81	-187.08	-133.34	-90.53
Total Common Equity	287.67	42.01	5.68	-182.92	-130.71	-89.21
Shareholders' Equity	287.67	42.01	5.68	-71.48	-19.27	22.24
Total Liabilities & Equity	297.2	61.78	92.33	47.06	61.77	35.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	5.12	15.34	18.9	50.84	44.73	4.97
Net Cash (Debt)	284.47	32.95	59.06	-25.22	-0.84	27.28
Net Cash Growth	788.56%	-44.21%	-	-	-	-
Net Cash Per Share	13.99	2.68	6.12	-72.26	-0.12	4.21
Filing Date Shares Outstanding	29.92	14.63	12.2	11.93	7.14	6.47
Total Common Shares Outstanding	29.89	12.86	12.2	7.47	7.14	6.47
Working Capital	285.96	43.7	65.41	14.61	-11.01	26.78
Book Value Per Share	9.62	3.27	0.47	-24.48	-18.31	-13.79
Tangible Book Value	287.67	42.01	5.68	-182.92	-130.71	-89.21
Tangible Book Value Per Share	9.62	3.27	0.47	-24.48	-18.31	-13.79
Machinery	1.82	1.82	1.82	1.81	1.81	0.31
Leasehold Improvements	1	1	1	0.94	0.94	-

SEC Filings: 10-K · 10-Q